Grifols Stock News

The European Central Bank has asked some lenders to detail their exposure to Spain's Grifols and its related entities, after the drugmaker was last week accused of manipulating its financial accounts

Grifols (GRFS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates c

Spanish pharma company Grifols said on Sunday evening Chinese home appliance maker Haier Group still plans to close the acquisition of a 20% stake in Shanghai RAAS Blood Products as announced in late

Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Zoetis (ZTS). But which of these two stocks presents investors with the better value opportun

Gotham City's recent allegations against Grifols have caused GFRS stock to significantly decline. Our team at Mare will remain waiting for clarifications. We expect the company's stock to be under pre

Shares of Spanish pharmaceutical company Grifols (NASDAQ: GRFS ) are plunging lower following the publication of a short report from Gotham City Research. The research firm has alleged that Grifols ha

The head of the Spanish CNMV stock market supervisor Rodrigo Buenaventura said it made no sense to question the integrity of the audited accounts of drugmaker Grifols or to ignore a report on Tuesday

Spanish blood plasma company Grifols saw its shares plunge more than 40% at one point on Tuesday after hedge fund Gotham City Research questioned the Madrid-listed group's financial reporting.

Spanish pharmaceutical company Grifols is set to hold a board meeting on Tuesday afternoon in reaction to a report from Gotham City Research questioning the company's accounting released earlier, boar

From their current levels, it would be no surprise if Direct Digital (DRCT), Vaalco Energy (EGY), and Grifols' (GRFS) stock moved much higher in 2024.

Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Zoetis (ZTS). But which of these two companies is the best option for those looking for under

Does Grifols (GRFS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Grifols (GRFS), Denison Mine Corp (DNN), NGL Energy Partners (NGL), Macatawa Bank (MCBC) and Navient (NAVI) have been selected as the breakout stocks for today.

Argenx's failure removes competitive pressure on Grifols' immunoglobulin franchise. Grifols is in advanced negotiations to sell Shanghai RAAS, which would eliminate short-term debt concerns. Grifols'

Grifols, S.A. (NASDAQ:GRFS ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Nuria Pascual - IR and Sustainability Officer Thomas Glanzmann - Executive Chairman and C